Aptose Biosciences is a biopharmaceutical company focused on the discovery, research and development of novel, first-in-class anticancer therapies with high safety profiles. Through its own discovery efforts, as well as partnering activities, Lorus is building a portfolio of promising anticancer drugs ranging from discovery and preclinical to clinical-proof-of concept stage. Lorus seeks suitable partners for subsequent late-stage registration trials and eventual commercialization.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
14
Frequently Asked Questions
What is Market Cap of Aptose Biosciences Inc?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Aptose Biosciences Inc market cap is $4.31M.
What is the 52-week high for Aptose Biosciences Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Aptose Biosciences Inc 52 week high is $1.85 as of July 22, 2026.
What is the 52-week low for Aptose Biosciences Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Aptose Biosciences Inc 52 week low is $0.8866 as of July 22, 2026.
What is Aptose Biosciences Inc stock price today?
Aptose Biosciences Inc stock price today is $1.69.
What was Aptose Biosciences Inc stock price yesterday?
Aptose Biosciences Inc stock price yesterday was $1.68.
What is the PE ratio of Aptose Biosciences Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Aptose Biosciences Inc's P/E ratio is -0.16.
What is the Price-to-Book ratio of Aptose Biosciences Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Aptose Biosciences Inc P/B ratio is -0.1244.
What is the 50-day moving average of Aptose Biosciences Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Aptose Biosciences Inc 50-day moving average is $1.65.
How many employees does Aptose Biosciences Inc have?